Moody Lynn & Lieberson LLC Has $3.76 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Moody Lynn & Lieberson LLC trimmed its holdings in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 20.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,415 shares of the biotechnology company’s stock after selling 2,415 shares during the period. Moody Lynn & Lieberson LLC’s holdings in Axon Enterprise were worth $3,762,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Mather Group LLC. increased its stake in Axon Enterprise by 3.7% during the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock worth $303,000 after acquiring an additional 27 shares during the period. CWM LLC increased its stake in Axon Enterprise by 1.3% during the 3rd quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock worth $1,141,000 after acquiring an additional 36 shares during the period. SPC Financial Inc. increased its stake in Axon Enterprise by 2.2% during the 3rd quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company’s stock worth $708,000 after acquiring an additional 38 shares during the period. Dorsey Wright & Associates increased its stake in Axon Enterprise by 0.3% during the 2nd quarter. Dorsey Wright & Associates now owns 14,053 shares of the biotechnology company’s stock worth $4,135,000 after acquiring an additional 39 shares during the period. Finally, Legacy Capital Group California Inc. increased its stake in Axon Enterprise by 5.7% during the 3rd quarter. Legacy Capital Group California Inc. now owns 724 shares of the biotechnology company’s stock worth $289,000 after acquiring an additional 39 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Up 0.1 %

Shares of AXON opened at $443.12 on Friday. The company has a market capitalization of $33.44 billion, a PE ratio of 129.57, a PEG ratio of 12.05 and a beta of 0.94. Axon Enterprise, Inc. has a 12 month low of $199.29 and a 12 month high of $455.17. The stock’s 50-day moving average price is $394.67 and its two-hundred day moving average price is $335.42. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35.

Axon Enterprise (NASDAQ:AXONGet Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. The company had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The firm’s revenue was up 34.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.80 EPS. On average, analysts anticipate that Axon Enterprise, Inc. will post 1.79 EPS for the current year.

Analysts Set New Price Targets

AXON has been the topic of a number of recent research reports. Bank of America started coverage on Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $380.00 price objective on the stock. Barclays lifted their price target on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Jefferies Financial Group started coverage on Axon Enterprise in a research note on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price target on the stock. Northland Securities lifted their price target on Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th. Finally, Robert W. Baird lifted their price target on Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a research note on Tuesday, September 10th. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $382.85.

Get Our Latest Research Report on Axon Enterprise

Insider Activity

In related news, CEO Patrick W. Smith sold 80,300 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the sale, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CEO Patrick W. Smith sold 70,000 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $362.21, for a total value of $25,354,700.00. Following the completion of the sale, the chief executive officer now directly owns 2,945,366 shares of the company’s stock, valued at $1,066,841,018.86. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Patrick W. Smith sold 80,300 shares of the business’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the sale, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 371,172 shares of company stock valued at $137,000,162 in the last ninety days. 6.10% of the stock is owned by company insiders.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Stories

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.